Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Dan Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3331-823X; OpenAlex author ID A5025123167. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective ph… Last author DOI 10.3389/fphar.2025.1562481↗
  2. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13402-024-00970-6↗
  3. Section the tumor and divest the arterial sheath in a patient with locally advanced pancreatic cancer. Co-author DOI 10.1016/j.asjsur.2022.07.125↗
  4. Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled tria… Last author DOI 10.1097/md.0000000000015761↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huanji Xu · 1 shared paper, 2025 · strength 0.30
  2. Qingqing Leng · 1 shared paper, 2025 · strength 0.30
  3. Xin Wang · 1 shared paper, 2025 · strength 0.30
  4. Yi Zhang · 1 shared paper, 2023 · strength 0.26
  5. Bole Tian · 1 shared paper, 2023 · strength 0.26
  6. Yi Jin · 1 shared paper, 2023 · strength 0.26
  7. Chengjian Zhao · 1 shared paper, 2024 · strength 0.26
  8. Xiaoying Li · 1 shared paper, 2024 · strength 0.26
  9. Wanting Hou · 1 shared paper, 2024 · strength 0.26
  10. Qiancheng Hu · 1 shared paper, 2019 · strength 0.11
  11. Peng Cao · 1 shared paper, 2019 · strength 0.11
  12. Ye Chen · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.